PRESS RELEASE

The number of new HIV diagnoses in the Netherlands is rising

Amsterdam, 19 November 2026

Ahead of World AIDS Day, Stichting hiv monitoring (SHM) has issued below press release to announce the publication of its 2026 HIV Monitoring Report for the Netherlands.

In 2025, 500 new HIV diagnoses were registered in the Netherlands. The latest figures show that the number of HIV diagnoses has been increasing since 2022¹. In previous years, the number stood at 489 (2024), 484 (2023), 446 (2022), 425 (2021) and 441 (2020).

Furthermore, model-based estimates of the number of undiagnosed HIV infections also predict that the number of HIV diagnoses will continue to rise in the coming years.

Professor Marc van der Valk, infectious diseases specialist and board member of Stichting hiv monitoring, says: “This year, we see an increase in the number of confirmed HIV diagnoses in the Netherlands. Without intervention, we expect the number of HIV diagnoses to continue to rise in coming years.”

Targeted HIV prevention among young people is needed
The number of new HIV diagnoses has increased in recent years especially among people born in or after 1990. This is even more the case for men who have sex with men (MSM): 47% of MSM diagnosed with HIV between 2023 and 2025 were born in or after 1990. The corresponding figures for other men and for women were 29% and 30%, respectively.

Regular HIV testing
Data show that 70% of MSM diagnosed with HIV between 2023 and 2025 had previously at least once tested negative for HIV. Of these, 35% had a last negative HIV test within 12 months preceding their HIV diagnosis. This indicates a recent HIV infection. Among MSM born in or after 1990, this figure was 45%, compared with 27% among MSM born before 1990. The corresponding figures for other men were 17% and 7%, respectively, and for women 7% and 5%.

“Diagnoses of recent HIV infections among men who have sex with men is a positive development. It shows that people are getting tested for HIV regularly,” says Professor Marc van der Valk.

“However, the figures also show that many men have been in contact with healthcare professionals quite recently to discuss the result of a negative HIV test. These are opportunities to start conversations about HIV prevention and could possibly help prevent new HIV infections.”

More use of the HIV prevention pill PrEP
An increasing proportion of people diagnosed with HIV have previously used PrEP². In 2025, 21% of MSM and transgender people with a new HIV diagnosis indicated to have previously used PrEP, compared to 7% in 2020.

“This does not mean that PrEP is ineffective,” explains van der Valk. “Rather, it can indicate inconsistent use of PrEP or people stop using it. Improving PrEP care can help prevent HIV infections. For example this could include providing better medical support for people taking PrEP and ensuring follow-up when people stop using it.”

Of 407 MSM and transgender people diagnosed with HIV between 2020 and 2025, reasons for not using PrEP are known. Twenty-four per cent believed they were at low risk of acquiring HIV, while 22% reported having no access to PrEP or being on a waiting list. Sixteen per cent did not know what PrEP is. By contrast, 21% said they did not want to use PrEP, and 17% already had an HIV infection at the time of their PrEP intake appointment.

Declining costs of HIV care³˒⁴
In 2024, the total cost of HIV care in the Netherlands amounted to €191 million. Of this, €150 million was spent on HIV medication, €39 million on outpatient care and €2 million on hospital admissions. In 2016, total costs amounted to €254 million, of which €211 million was spent on HIV medication, €39 million on outpatient care and €3.5 million on hospital admissions.

Between 2016 and 2024, the number of people receiving HIV care in the Netherlands increased by 17%, from 17,930 to 21,000. At the same time, inflation-adjusted healthcare costs per person receiving HIV care decreased by 36%, from €14,152 in 2016 to €9,108 in 2024.

“Since 2016, inflation-adjusted healthcare costs per person receiving HIV care have decreased by more than one third. This reduction is partly the result of the cost-effective prescribing of medication by HIV specialists,” explains van der Valk.

Latest figures known to SHM: in the Netherlands at the end of 2025 there are

  • An estimated 26,225 people living with HIV.
  • 23,491 people living with HIV in care at one of the 23 HIV treatment centres.
  • 22,602 people whose HIV has been successfully suppressed through treatment. They can therefore no longer transmit the virus.
  • An estimated 1,650 people who are still unaware that they have HIV. At the end of 2024, this estimated figure was 1,600.
  • In 2025, 19 people died as a result of advanced HIV infection (AIDS). This figure has remained broadly stable since 2015.

These and other data can be found in the summary of the 2026 HIV Monitoring Report : www.hiv-monitoring.nl/2026

 

______________________


1 SHM's annual publication of latest HIV trends provides a snapshot at a particular point in time. As people living with HIV must give their consent before their data can be included in SHM's data collection, there is often a delay in the registration of new HIV diagnoses. When SHM analyses the figures a following year, the number of registered HIV diagnoses for previous years are therefore higher than previously reported.

2 PrEP (Pre-Exposure Prophylaxis) is a medication that people who do not have HIV can take to prevent acquiring HIV. PrEP is most effective when taken as prescribed medication and accompanied by support from a doctor or medical specialist. Since 2019, PrEP has been available in the Netherlands through the national PrEP.

3 SHM compiled these data in collaboration with the Amsterdam Health Technology Institute (AHTI), using Statistics Netherlands (CBS) microdata and healthcare cost data from Vektis. Vektis data are available up to and including 2024.

4 Adjusted for healthcare price increases using the Dutch Healthcare Authority (NZa) healthcare price index.